In the treatment of mild to moderately severe cases of chronic skin disease associated with a thickened dry, flaky and itchy skin such as all forms of chronic eczema, neurodermatitis, psoriasis, etc.

Apply a thin layer of Salidex® on the affected skin areas one to two times daily or as directed by physician. An occlusive dressing should be applied upon doctor’s recommendation only, Salidex Topical Solution is non greasy and suitable for treatment of the hairy areas of the body.

Hypersensitivity to the active substance or to any of the excipients, Salidex must not be used in the case of skin infections such as tuberculosis of the skin, Syphilis, viral infections, (Chicken pox, herpes zoster) or vaccination reaction .the preparation must not be used by infants. It is also not suitable for the treatment of severely inflamed, weeping or exudative conditions.

The patient should not exceed the treatment period and area of application recommended by the physician, as skin damage may otherwise occur.

No interaction studies have been performed. Interactions with systemically administered medicinal products are considered minimal as the systemic absorption of topical Salidex Topical Solution is negligible.

Although no adverse effects have been reported following application of Salidex® during pregnancy, animal studies indicate a risk of deformity at high dose levels. For these reasons, this product should not be used during pregnancy, especially during the first trimester.
Lactating mothers should only apply the preparation for short period and to small areas. In all cases, use of this product is subjected to medical advice.

Salidex Topical Solution administered topically has no or negligible influence on the ability to drive or to use machines.

Local side effects such as skin irritation. Burning sensation, itching and dryness as well as hypersensitivity reactions may occur.

Overdose is unlikely to occur.

ATC Code: D07XB05
Salicylic acid is applied topically in the treatment of hyperkeratotic and scaling conditions where its keratotic action facilitates penetration of the corticosteroid.
In pharmacological doses, corticosteroids are used primarily for their anti-inflammatory and/or immune suppressive effects.
Topical corticosteroids such as dexamethasone are effective in the treatment of a range of dermatoses because of their anti-inflammatory, anti-pruritic and vasoconstrictive actions. However, while the physiologic, pharmacologic and clinical effects of the corticosteroids are well known, the exact mechanisms of their action in each disease are uncertain

Salicylic acid exerts only local action after topical application.
The extent of percutaneous absorption of topical corticosteroids is determined by many factors including vehicle, integrity of the epidermal barrier and the use of occlusive dressings.
Topical corticosteroids can be absorbed through intact, normal skin. Inflammation and/or other disease processes in the skin may increase percutaneous absorption.
Occlusive dressings substantially increase the percutaneous absorption of topical corticosteroids.
Once absorbed through the skin, topical corticosteroids enter pharmacokinetic pathways similar to systemically administered corticosteroids. Corticosteroids are bound to plasma proteins in varying degrees, are metabolized primarily in the liver and excreted by the kidneys. Some of the topical corticosteroids and their metabolites are also excreted in the bile

There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.

Isopropyl Alcohol Propylene Glycol Sodium Hydroxide Purified Water

Not applicable

2 years

Store below 30°C

30 ml Plastic bottle

Not applicable